Haemostatic function, arterial disease and the prevention of arterial thrombosis.
MRC Epidemiology and Medical and Care Unit, Wolfson Institute of Preventive Medicine, Medical College of St. Bartholomew's Hospital, London, UK.
T W
TW
Meade
D000328:Adult; D000368:Aged; D000925:Anticoagulants / Q000627:therapeutic use; D001158:Arteries; D001241:Aspirin / Q000627:therapeutic use; D001779:Blood Coagulation Factors / Q000502:physiology; D002318:Cardiovascular Diseases / Q000097:blood / Q000150:complications / Q000453:epidemiology*; D016022:Case-Control Studies; D002986:Clinical Trials as Topic; D005167:Factor VII / Q000032:analysis; D005169:Factor VIII / Q000032:analysis; D005260:Female; D005340:Fibrinogen / Q000032:analysis / Q000037:antagonists & inhibitors; D005342:Fibrinolysis; D005343:Fibrinolytic Agents / Q000494:pharmacology / Q000627:therapeutic use; D006467:Hemophilia A / Q000150:complications / Q000401:mortality; D006487:Hemostasis; D006801:Humans; D008297:Male; D008875:Middle Aged; D008954:Models, Biological; D008955:Models, Cardiovascular; D011446:Prospective Studies; D012044:Regression Analysis; D012307:Risk Factors; D013927:Thrombosis / Q000097:blood / Q000209:etiology / Q000517:prevention & control*
D000925:Anticoagulants; D001779:Blood Coagulation Factors; D005343:Fibrinolytic Agents; D005167:Factor VII; D005169:Factor VIII; D005340:Fibrinogen; D001241:Aspirin